Sort   by:  
 Page size 
TranscriptomicsTranscription profiling of human thyrocytes stably expressing wild type RET/PTC1 oncogene or RET/PTC1 carrying Y451F mutation and parental thyrocytes
Mass populations of thyrocytes stably expressing wild type RET/PTC1 oncogene or RET/PTC1 carrying Y451F mutation and parental thyrocytes were used for hybridization on Affymetrix HG-U133A and HG-U133B chips. For each cell condition were generated two different targets (indicated as two different sam...
ORGANISM(S): Homo sapiens 
2005-09-30 | E-MEXP-429 | biostudies-arrayexpress
TranscriptomicsmiRNA profile induced by RET/PTC1 oncogene in human thyrocytes
To obtain a PTC cell model, primary human thyrocytes have been infected with a retrovirus expressing RET/PTC1 oncogene, using parental thyrocytes as control. The obtained RET/PTC-dependent differential miRNA expression profile, representing the effects of RET/PTC1 oncogene present in about one third...
ORGANISM(S): Homo sapiens 
2014-06-30 | E-GEOD-49400 | biostudies-arrayexpress
TranscriptomicsmicroRNA expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1
We treated the papillary thyroid carcinoma-derived cell line TPC1 with the RTK inhibitor RPI-1 to obtain a thyroid carcinoma cell model. The RET tyrosine kinase is a target of the inhibitor. microRNA expression changes were evaluated comparing cells treated with the inhibitor fo 24 hours versus cell...
ORGANISM(S): Homo sapiens 
2014-06-30 | E-GEOD-49401 | biostudies-arrayexpress
TranscriptomicsGene expression profiling in TPC1 cell line treated with the RTK inhibitor RPI-1
We treated the papillary thyroid carcinoma-derived cell line TPC1 with the RTK inhibitor RPI-1 to obtain a thyroid carcinoma cell model. The RET tyrosine kinase is a target of the inhibitor. Gene expression changes were evaluated comparing cells treated with the inhibitor for 24 hours versus cells t...
ORGANISM(S): Homo sapiens 
2014-06-30 | E-GEOD-49414 | biostudies-arrayexpress
Sort   by:  
 Page size